-
Ustekinumab, sold
under the
brand name
Stelara among others, is a
monoclonal antibody medication used for the
treatment of Crohn's disease, ulcerative...
-
program comprising four
clinical trials which compared risankizumab to
ustekinumab,
adalimumab and
placebo in the
indication of
plaque psoriasis. The results...
-
treatment with
ustekinumab. It
showed that
patients who
switched to
guselkumab from
ustekinumab did
better than
those who
remained on
ustekinumab. "Tremfya...
- (USAN, INN)
ustekinumab-aauz
ustekinumab-aekn
ustekinumab-auub
ustekinumab-kfce
ustekinumab-srlf
ustekinumab-stba
ustekinumab-ttwe
ustekinumab (USAN, INN)...
- needed]
Ustekinumab (CNTO 1275) is a
monoclonal antibody that
suppresses cytokines IL-12 and IL-23.
Originally designed to
treat psoriasis,
ustekinumab was...
-
bimekizumab is
superior to not only
adalimumab but also
secukinumab and
ustekinumab for the
treatment of
plaque psoriasis. The
approval for the treatment...
- tocilizumab-bavi/Tofidence tocilizumab/Actemra
October 2023
ustekinumab-auub/Wezlana
ustekinumab/Stelara
December 2023 bevacizumab-tnjn/Avzivi bevacizumab/Avastin...
- such as
vedolizumab and
natalizumab and
interleukin antagonists like
ustekinumab.
Prior to the
development of
biological therapy as a
modality to treat...
- Armando; Moreira, Ana
Isabel (2016-05-24). "Inverse
psoriasis treated with
ustekinumab". BMJ Case Reports. BMJ: bcr2016215019. doi:10.1136/bcr-2016-215019....
-
serious side
effects or infections,
except for mild
nasal infections.
Ustekinumab,
approved for
moderate to
severe Crohn's
disease in
October 2016, has...
